Yesterday, leading advanced IT solutions company Beacon Enterprise Solutions Group, Inc. announced the execution of a new purchase order with a Fortune 500 Pharmaceutical Company that will encompass both domestic and international locations, including Germany, Spain, Italy, France, Canada, Australia, the Netherlands and the UK. The Fortune 500 customer, headquartered in New Jersey, is a global research driven pharmaceutical company, focused on discovering, developing, manufacturing and marketing vaccines and medicines.

The new order relates to Layer 1 infrastructure services for a recently acquired entity of the pharmaceutical company. The client is an existing Beacon customer and uses Beacon’s IT infrastructure provisioning expertise to assist it in assessing and integrating the entity’s network in the medical space.

Beacon Solutions CEO Bruce Widener stated, “This most recent order is a testament to our excellent reputation and our client’s willingness to continue to engage Beacon and our experienced team of IT infrastructure professionals. This project further expands our reach throughout Europe and into previously un-serviced countries such as Australia. We look forward to continuing to work with this Fortune 500 client as they undergo the task of integrating their recent acquisition, in addition to servicing their future IT infrastructure needs.”